https://orcid.org/0000-0001-8770-1042
About the Authors
- Peter J. Hotez
-
* E-mail: hotez@bcm.edu (PJH); jorgehuete@uca.edu.ni (JAHP); bottazzi@bcm.edu (MEB)
Affiliations Texas Children’s Center for Vaccine Development, Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Department of Biology, Baylor University, Waco, Texas, United States of America, Hagler Institute for Advanced Study at Texas A&M University, College Station, Texas, United States of America, James A Baker III Institute for Public Policy, Rice University, Houston, Texas, United States of America, Scowcroft Institute of International Affairs, Bush School of Government and Public Service, College Station, Texas, United States of America
- Jorge A. Huete-Perez
-
* E-mail: hotez@bcm.edu (PJH); jorgehuete@uca.edu.ni (JAHP); bottazzi@bcm.edu (MEB)
Affiliation Molecular Biology Center, University of Central America, Managua, Nicaragua
- Maria Elena Bottazzi
-
* E-mail: hotez@bcm.edu (PJH); jorgehuete@uca.edu.ni (JAHP); bottazzi@bcm.edu (MEB)
Affiliations Texas Children’s Center for Vaccine Development, Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Department of Biology, Baylor University, Waco, Texas, United States of America
Competing Interests
MEB and PJH are inventors of a low cost COVID19 vaccine for global health which was recently licensed by Baylor College of Medicine to a commercial third party for scale up and production.